[go: up one dir, main page]

IL164905A0 - Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions co ntaining the novel forms and methods for trearing nausea using them - Google Patents

Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions co ntaining the novel forms and methods for trearing nausea using them

Info

Publication number
IL164905A0
IL164905A0 IL16490504A IL16490504A IL164905A0 IL 164905 A0 IL164905 A0 IL 164905A0 IL 16490504 A IL16490504 A IL 16490504A IL 16490504 A IL16490504 A IL 16490504A IL 164905 A0 IL164905 A0 IL 164905A0
Authority
IL
Israel
Prior art keywords
novel
forms
trearing
ntaining
ondansetron
Prior art date
Application number
IL16490504A
Other languages
English (en)
Original Assignee
Biogal Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Pharmaceutical Co Ltd filed Critical Biogal Pharmaceutical Co Ltd
Publication of IL164905A0 publication Critical patent/IL164905A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16490504A 2002-04-30 2004-10-28 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions co ntaining the novel forms and methods for trearing nausea using them IL164905A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37639502P 2002-04-30 2002-04-30
PCT/US2003/013220 WO2003093260A1 (fr) 2002-04-30 2003-04-29 Nouvelles formes cristallines d'ondansetron, procedes de preparation correspondant, compositions pharmaceutiques contenant ces nouvelles formes et procedes de traitement de la nausee au moyen des ces nouvelles formes

Publications (1)

Publication Number Publication Date
IL164905A0 true IL164905A0 (en) 2005-12-18

Family

ID=29401340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16490504A IL164905A0 (en) 2002-04-30 2004-10-28 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions co ntaining the novel forms and methods for trearing nausea using them

Country Status (15)

Country Link
US (1) US20040019093A1 (fr)
EP (1) EP1465887A1 (fr)
JP (1) JP2005529908A (fr)
KR (1) KR20040104677A (fr)
CN (1) CN1665803A (fr)
AU (1) AU2003223763A1 (fr)
CA (1) CA2483532A1 (fr)
DE (1) DE20320528U1 (fr)
HR (1) HRP20041136A2 (fr)
IL (1) IL164905A0 (fr)
MX (1) MXPA04010845A (fr)
NO (1) NO20045233L (fr)
PL (1) PL373192A1 (fr)
WO (1) WO2003093260A1 (fr)
ZA (1) ZA200408935B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20030432A2 (en) * 2000-10-30 2004-06-30 Teva Pharma Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
WO2003093281A1 (fr) * 2002-04-29 2003-11-13 Biogal Gyogyszergyar Rt. Methode de preparation de 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
ES2238001B1 (es) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
CA2565854A1 (fr) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Procede de preparation de chlorhydrate dihydrate d'ondansetron ayant une granulometrie definie
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
MX2009003372A (es) 2006-10-02 2009-09-24 Labtec Gmbh Formas de dosificacion de pelicula no mucoadhesiva.
EP2377526A1 (fr) 2010-03-23 2011-10-19 BioAlliance Pharma Systèmes d'administration de médicaments à dissolution rapide
EP2549988A1 (fr) 2010-03-23 2013-01-30 Apr Applied Pharma Research S.A. Systèmes d'administration de médicaments à dissolution rapide
SG10202012791TA (en) 2013-11-15 2021-01-28 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
CA2106642C (fr) * 1992-10-14 2005-08-16 Peter Bod Derives de carbazolone et procede d'obtention
CA2150089A1 (fr) * 1994-07-08 1996-01-09 Andrew L. Itzov Mecanisme de reglage de l'angle de biseau d'une scie a onglet combinee
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
JP3533519B2 (ja) * 2000-03-09 2004-05-31 株式会社アドバンスト・ディスプレイ Ｔｆｔ基板、フィルムキャリアおよび液晶表示素子の製法
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
WO2003093281A1 (fr) * 2002-04-29 2003-11-13 Biogal Gyogyszergyar Rt. Methode de preparation de 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one

Also Published As

Publication number Publication date
KR20040104677A (ko) 2004-12-10
CN1665803A (zh) 2005-09-07
HRP20041136A2 (en) 2005-04-30
MXPA04010845A (es) 2005-01-25
PL373192A1 (en) 2005-08-22
JP2005529908A (ja) 2005-10-06
EP1465887A1 (fr) 2004-10-13
CA2483532A1 (fr) 2003-11-13
AU2003223763A1 (en) 2003-11-17
NO20045233L (no) 2005-01-28
DE20320528U1 (de) 2004-09-16
US20040019093A1 (en) 2004-01-29
ZA200408935B (en) 2006-07-26
WO2003093260A1 (fr) 2003-11-13

Similar Documents

Publication Publication Date Title
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
IL164857A (en) 1-thia-4,8,diaza-spiro[4.5]decan-3-one compounds, process for preparation thereof and pharmaceutical compositions comprising them
AU2003243354A8 (en) Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
IL183583A (en) Quinazoline History and Pharmaceuticals Containing Them and Methods of Manufacturing
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
IL172512A0 (en) Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
EP1551833A4 (fr) Procede de preparation de (s,s)-cis-2-benzhydryl-3-benzylaminoquinuclidine
SI1720544T1 (sl) Novi azabicikliäśni derivati, postopek za njihovopripravo in farmacevtski sestavki, ki jih vsebujejo
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
HUP0401523A2 (en) Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them
IL164905A0 (en) Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions co ntaining the novel forms and methods for trearing nausea using them
AU2003232941A1 (en) N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
HUP0203976A3 (en) Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
IL171789A (en) Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
AU2003225426A1 (en) Process for the preparation of urea
EG23973A (en) Process for the preparation of urea ganules
IL182445A0 (en) Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfona mido-dibenzo[b,d]furan-1-caboxamide
EP1556364A4 (fr) Derives d'isothiazole, procede permettant leur preparation et composition pharmaceutique contenant ces derives
IL173631A0 (en) Crystal forms of 1-methyl carbapenem, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2003229863A1 (en) Porphyrin derivatives, method for the production thereof, pharmaceutical compositions and use thereof